Key facts
- It has raised $3.3M; the latest was Later Stage VC ($2.8M) in Mar 2026.
- Notable investors include Texas Medical Center, Engage Venture Partners, Ocho Capital, Startup Warrior.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for ReX
- ·The full record, as it builds
Funding rounds
No funding rounds for ReX are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About ReX
Developer of a connected medication management platform designed to support patient care teams in delivering and tracking treatments remotely. The company's platform offers a connected dispensing device, real-time adherence tracking, secure data handling, integration with care teams, and patient-reported outcome monitoring, enabling healthcare providers and patients to improve treatment adherence, maintain continuous communication, and support care management throughout the treatment process.
- Sector
- Healthcare
- HQ
- Plymouth, MN, United States
- Founded
- 2011
- Employees
- 37
- Website
- dosentrx.com/
- Ownership
- Privately Held (backing)
ReX doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ReX shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ReX in its N-PORT filings yet. We sweep new filings monthly.